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Abstract
Injectable bone substitutes are generally composite materials capable of being extruded through a device; they 
consist of a solid phase inside a matrix that allows the easy movement of particles. Injectable bone substitutes have 
the advantage of allowing its application in situ without the need of invasive surgical techniques, guaranteeing a 
good recovery; for this reason, they are a promising alternative to replace conventional techniques to repair bone 
defects. Conventional techniques include the use of allografts and autografts, which often cause adverse reactions, 
and are disadvantageous for both the patient and the doctor. Furthermore, there are no reports regarding bone 
substitute development in Colombia, creating the necessity to research composite materials that could become 
injectable bone substitutes. In this study, we manufactured injectable bone substitutes with hydroxyapatite and 
calcium phosphate, which is most similar to bone tissue, and synthesized them in nanorods with shape and size 
similar to the natural hydroxyapatite found inside the body. Additionally, we used extracted silk fibroin from 
silkworm cocoons of Bombyx mori, a natural polymer of protein nature with high mechanical properties and 
excellent biocompatibility. For the materials manufactured, we evaluated degradation, in a simulated body fluid 
(SBF) at normal body temperature, water uptake, injectability and mechanical strength. The manufactured bone 
substitutes showed good degradation and water uptake properties, an approximate 97% injectability, and low 
mechanical resistance, indicating promising properties to be used as an injectable bone substitute.
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Resumen
Los sustitutos óseos inyectables son materiales compuestos que tienen la propiedad de dejarse extruir a través de 
un dispositivo; constan de una fase sólida inmersa en una matriz que permite el fácil movimiento del componente 
sólido, y tienen como ventaja permitir su aplicación in situ sin necesidad de recurrir a técnicas quirúrgicas 
invasivas, garantizando una buena recuperación; razón por la que son considerados una buena alternativa para 
reemplazar las técnicas convencionales para la reparación de defectos óseos, las cuales incluyen, principalmente, 
el uso de aloinjertos y autoinjertos, que generan una serie de reacciones adversas y tienen desventajas tanto para 
el médico como para el paciente. En Colombia no se encuentran reportes acerca del desarrollo de sustitutos óseos; 
esto genera la necesidad de investigar un material compuesto que tenga potencial aplicación como sustituto óseo 
inyectable. En la presente investigación se fabricaron sustitutos óseos de hidroxiapatita –fosfato de calcio que 
mayor similitud presenta con el tejido óseo–, sintetizada en nanobarras, con tamaño y forma similar a como 
se dispone naturalmente en el hueso; y la fibroína de seda extraída de los capullos del gusano Bombyx mori, 
como polímero natural de naturaleza proteica con altas propiedades mecánicas y excelente biocompatibilidad. Los 
materiales fabricados se caracterizaron por degradación en solución fisiológica a temperatura corporal, absorción 
de agua, inyectabilidad y resistencia mecánica. Los sustitutos óseos fabricados presentaron buenas propiedades 
de degradación y absorción, una inyectabilidad aproximada del 97 % y baja resistencia mecánica, mostrando 
propiedades promisorias para usarse como sustituto óseo inyectable.
Palabras clave: biomateriales; cerámicos; materiales compuesto; polímeros; sustitutos óseos.
Resumo
Os substitutos ósseos injetáveis são materiais compostos que têm a propriedade de deixar-se extruir através de um 
dispositivo; constam de uma fase sólida imersa em uma matriz que permite o fácil movimento do componente 
sólido, e têm como vantagem permitir sua aplicação in situ sem necessidade de recorrer a técnicas cirúrgicas 
invasivas, garantindo uma boa recuperação; razão pela qual são considerados uma boa alternativa para substituir 
as técnicas convencionais para a reparação de defeitos ósseos, as quais incluem, principalmente, o uso de 
aloenxertos e autoenxertos, que geram uma série de reações adversas e têm desvantagens tanto para o médico 
como para o paciente. Na Colômbia não se encontram relatos acerca do desenvolvimento de substitutos ósseos; 
isto gera a necessidade de pesquisar um material composto que tenha potencial aplicação como substituto ósseo 
injetável. Na presente pesquisa fabricaram-se substitutos ósseos de hidroxiapatita –fosfato de cálcio que maior 
semelhança apresenta com o tecido ósseo–, sintetizada em nanobarras, com tamanho e forma similar àquela 
que se dispõe naturalmente no osso; e a fibroína de seda extraída dos casulos do bicho da seda Bombyx mori, 
como polímero natural de natureza proteica com altas propriedades mecânicas e excelente biocompatibilidade. 
Os materiais fabricados caracterizaram-se por degradação em solução fisiológica à temperatura corporal, absorção 
de água, injetabilidade e resistência mecânica. Os substitutos ósseos fabricados apresentaram boas propriedades 
de degradação e absorção, uma injetabilidade aproximada de 97% e baixa resistência mecânica, mostrando 
propriedades promissoras para usar-se como substituto ósseo injetável. 
Palavras chave: biomateriais; cerâmicos; materiais compostos; polímeros; substitutos ósseos.
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I. IntroductIon
Worldwide, bone defects represent a common health 
problem, usually caused by various diseases, fractures 
or congenital problems that require different bone 
repair techniques to fix them. Currently, numerous 
types of grafts, classified according to their origin, 
are use clinically: autografts from the same patient, 
allografts from the same species, xenografts from 
other species, such as deproteinized bovine bone, 
and alloplastic bone substitutes that are synthetically 
manufactured [1-3].
Autografts have biocompatibility advantages and 
excellent osteogenic properties. However, they have 
disadvantages in terms of the extraction site, which 
usually is in the iliac crest or other bones such as tibia 
and femur; this extraction involves double surgery, 
increase pain, morbidity of the extraction site, and 
quantity of bone available according to the amount of 
tissue needed to correct the defect [1, 2]. Allografts 
provide biocompatibility properties, different 
reconstruction options, and replacement of bone parts. 
However, despite being a good option, they represent 
a structural failure risk compared to autografts, since 
the mechanical and biological properties of the 
bone change depending on the location in the body. 
Additionally, allografts are subjected to processes 
and treatments such as radiation and lyophilization 
to reduce the risk of disease transmission and 
immunological disorders, although they are not 
always completely successful [1, 3]. In contrast, 
xenografts have had good results in small portions of 
bone, although their main disadvantage is the risk of 
immunological reactions, and transmission of viral 
and infectious diseases [4-7].
Alloplastic bone substitutes have been widely 
researched and are becoming more frequently used 
since they offer multiple options and compositions 
with which they can be manufactured. Bioceramic 
bone substitutes, such as calcium phosphates, are the 
most researched due to their good biocompatibility, 
osteoconduction and osseointegration properties [4, 8, 
9]; they are usually manufactured in rigid forms, which 
prevents the filling of cavities with complex shapes. 
Furthermore, injectable bone substitutes have been 
studied because they offer many clinical application 
benefits, primarily in surgeries, to correct bone defects 
and fill cavities; they represent an easy method at the 
surgical level and are less traumatic for the patients 
[10]. Injectable systems are usually composite 
materials, manufactured with calcium phosphates and 
polymers that seek to have a composition similar to 
the bone [11, 12].
Hydroxyapatite (HA) is a calcium phosphate like the 
mineral found in bones. It has good polymer affinity 
and can provide excellent proliferation and cell 
adhesion when synthesized and used at the nanoscale 
(nHA). These characteristics make HA an appropriate 
material to develop an injectable system [13]. Silk is a 
polymeric material produced by insects such as spiders 
and silkworms like Bombyx mori; it is composed of 
two proteins: sericin and fibroin. Using silk fibroin 
(SF) as a biomaterial began in recent decades due 
to its good mechanical and biological properties; its 
excellent biocompatibility is due to its protein nature 
since proteins are present in living tissues. As a result, 
SF has been implemented in various applications 
such as hydrogels, films, macroparticles, scaffolds 
and injectable systems [12, 14, 15]. This work aims 
to develop an injectable bone substitute composed 
of hydroxyapatite nanorods (nHA) and silk fibroin 
produced by B. mori, and evaluate its degradation, 
water uptake, mechanical resistance and injectability, 
which will allow assessing whether it is possible to use 
it as an osseous substitute.
II. matErIals and mEthods
A. Synthesis and characterization of hydroxyapatite 
nanorods
HA nanorods (nHA) were synthesized from the 
following chemical reaction (1):
  
(1)
The Ca(NO3)24H2O and (NH4)2HPO4 were prepared in 
aqueous solutions of 0.5 M and 0.3 M, respectively, 
to guarantee a stoichiometric ratio of Ca/P=1.67. 
We adjusted the pH to 10 with ammoniacal solution, 
and later combined the solutions by dripping with 
magnetic stirring at a controlled speed. We placed 
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the final solution in a hermetic Teflon autoclave to 
undergo hydrothermal treatment for 24 h at 180 °C, 
and once the process finished, we cooled down the 
vessel at room temperature. We washed the solution 
with distilled water until reaching a neutral pH and 
dried it for 24 h at 80 °C to obtain a fine powder [16].
We used transmission electron microscopy with 
field emission (FE-SEM) and transmission electron 
microscopy (TEM) to observe the morphology of the 
particles, using the JEOL JSM 7100 and TECNAI F20 
SUPER TWIN TMP microscopes, respectively. We 
evaluated phase stabilization corresponding to HA and 
its crystallinity through X-ray diffraction (XRD) in a 
Rigaku X-ray equipment provided with a Cu source 
and an angle 2θ between 5° and 60°. We obtained 
the Ca/P ratio by X-ray Fluorescence (XRF) using a 
PANalytical minipal 2 spectrometer with dispersive 
energy and direct excitation.
B. Fibroin (SF) preparation and characterization
To obtain the fibroin, first, we prepared the silkworm 
cocoons, which we cut into small pieces and then 
submerged them in an aqueous solution 0.1% wt/v of 
NaCO3 at 80 °C for one hour under magnetic stirring to 
remove the sericin [17, 18]. Subsequently, we washed 
the SF extract with distilled water and dissolved it in 
a solution of CaCl2, H2O and CH3CH2OH 1:8:2 molar 
between 45 °C and 55 °C for one hour [19-21]. The 
solution underwent a dialysis process, with distilled 
water in cellulose acetate membranes for five days to 
remove the inorganic salts remaining from the previous 
processes. We calculated the concentration of the final 
solution from the weight of the solid after the solution 
dried completely [21]. We characterized the SF through 
a Fourier Transform (FTIR-ATR) spectroscopy in a 
SHIMADZU IR TRACER 100 device and through 
polyacrylamide gel electrophoresis to calculate the 
molecular weight. The gel concentration was 4% for 
the gel separator and 10% for the concentrator gel; 
additionally, we used a Thermo Scientific protein 
marker of 10 to 180 kDa. The test was carried out in 
a MINI PROTEAN electrophoresis cell with an initial 
run of 80 V for 30 min and a final run of 120 V for 
120 min.
C. Preparation of injectable bone substitutes SF/
nHA
We used two concentrations (1% and 1.5%) of the 
SF solution from a concentrated solution of 2.5%; we 
mixed the solutions with glutaraldehyde (GTA) as a 
crosslinking agent, and subsequently, we added the 
nHA at 60% wt/v slowly under magnetic stirring for a 
period of one to two hours or until the material became 
viscous. We left the final mixture standing for 24 h to 
complete the crosslinking and to stabilize the polymer 
before using it [22-25].
D. In vitro degradation and water uptake
We enclosed the SF/nHA bone substitutes in 
cylindrical molds of 13.55 mm in diameter and 16 
mm in height to give them a defined shape, and dried 
them for three hours at 90 °C. For the degradation test 
we considered a modification of the ASTM F1634-95 
standard [26], hence, the substitutes were immersed 
in a solution of concentrated ionic salts or SBF with a 
pH of 7, following the protocol described by Kokubo 
and Takadama [27]; afterwards, the samples were 
incubated at 37 °C for 28 days. After we removed the 
samples from the solution and dried them as described 
above, we measured degradation by recording their 
mass on days 0, 1, 7, 14, 21, and 28, to observe the 
weight loss trend and calculate the percentage of 
degradation using equation (2). It should be noted that 
day 0 is the start day, thus the mass corresponds to the 
initial mass of the sample.
     (2)
Where M0 is the mass of the substitute on day 0 or 
the initial mass, and Mt is the mass of the substitute 
on days 1, 7, 14, 21 or 28. We evaluated water uptake 
through an in vitro degradation test on the same days 
(1, 7, 14, 21 and 28), following Silva et al. [28] and 
Oliveira et al. [29]. We measured the mass of the 
substitute immediately after we removed the sample 
from the SBF and before drying it, and calculated the 
water uptake percentage using equation (3).
     (3)
Where MH is the mass of the wet sample after being 
removed from the SBF on days 1, 7, 14, 21 and 28, 
and M0 is the initial mass or mass taken on day 0.
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E. Injectability and mechanical strength
To determine the force required to extrude the material 
through a device, we used a universal DIGIMESS 
testing machine with a load cell of 4900 N and a 
minimum speed of 5 mm/min. We placed the material 
in a 10 ml syringe with a 14 Gauge hypodermic needle 
and an inner diameter of 2.15 mm. The maximum force 
was 300 N with a speed of 10 mm/min. The universal 
machine was equipped with a compression plate on 
top and a handle at the bottom to hold the syringe. 
The force was applied vertically on the plate until the 
material was completely extruded or until the force 
reached 300 N, taking into account other protocols 
[30-32]. We calculated the injectability percentage 
using equation (4).
      (4)
Where Mext is the mass extruded by the syringe, and 
M0 is the mass of the material in the syringe before 
injection.
We measured mechanical strength through a 
compression test, modifying the ASTM C 1424-04 
standard and using the same DIGIMESS universal 
machine described in the injectability test [33]. 
The test pieces were made in cylindrical molds of 
approximately 18.4 mm in height and 19.2 mm in 
diameter.
III. rEsults and dIscussIon
A. Characterization of nanohydroxyapatite nHA
Figure 1 shows the FE-SEM and TEM micrographs 
of the nHA particles obtained by the precipitation 
and hydrothermal treatments. The image analysis 
processing software allowed observing the nanorods 
morphology. The average values obtained were 
246.13 ± 61.99 nm in length and 39.93 ± 8.37 nm 
in diameter. These results agree with other authors 
who synthesized HA nanorods through similar 
methods [34]. The TEM image (Fig. 1b) confirms the 
results, showing that the nanorods synthesized with 
agglomerates have characteristics of nanometer-scale 
materials; the morphology is comparable with that 
reported by other authors for powders manufactured 
using similar methods [35-37].
FIg. 1. Micrographs of nHA powder. a) FE-SEM and b) TEM.
The XRD pattern registered for the nHA powder 
obtained (Fig. 2) can be compared with a typical HA 
(JCPD 72-1243), displaying the main peaks at 2θ 
31.9°, 32.2° and 33.1°, and secondary peaks at 2θ 26°, 
34.3°, 40°, 46.9°, 49.7° and 53.4°, in addition to other 
peaks of lower intensity, all corresponding to HA. 
Peaks corresponding to the stabilized phase of other 
calcium phosphates were not evident, highlighting that 
the intensity and narrowing of the peaks shows that 
the material has good crystallinity properties, making 
it suitable for using it as a biomaterial according to 
ASTM F1185-03 [38-40].
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FIg. 2. Diffractogram of the HA powder obtained.
The XRF test results for the HA powder yielded 
a Ca/P ratio of 1.67, a value that corresponds to a 
stoichiometric HA, suitable for developing composite 
material; thus, we conclude that the material obtained 
by the methodology described here, not only favors 
the formation of nanorods and phase stabilization, 
but also guarantees an adequate molar ratio, which is 
reflected in the results and therefore is apt to be used 
as a biomaterial.
B. Characterization of fibroin
The SF structure consists of a chain of repeating amino 
acids, which are mainly glycine, alanine and serine, 
thus giving different types of molecular structures 
known as α-helix and β-sheets, also called silk I and 
silk II, respectively [41]. In the infrared spectroscopy 
(IR) spectrum for the fibroin obtained, the region of 
interest is located between 1000 and 1800 cm-1 (Fig. 
3), since this area is where the amides characteristics 
of the material are displayed, and depending on the 
value of the vibration bands, it can indicate whether 
they correspond to silk I or silk II. The bands at 1651, 
1514 and 1234 cm-1 in the spectrum refer to amides 
I, II and III, respectively, for silk I (α-helix); and at 
approximately 1639 and 1529 cm-1, the vibration bands 
of amides I and II corresponds to silk II (β-sheets). 
The presence of amide III is not clearly observed for 
this structure, but it is possible that the bands overlap 
since they are usually very close to amide III of silk 
I. In addition, the vibration band looks wide possibly 
concealing the band corresponding to the amide III 
of silk II, concluding that this band can be present 
between 1230 and 1270 cm-1 [28, 42, 43].
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FIg. 3. IR spectrum for the SF obtained. Amides I and II for β-sheets structure in light gray, and amides I, II and III 
for α-helix structure in dark gray.
Fibroin is a large protein that has two molecular 
chains, a heavy one reported between 250 and 390 
kDa and a light one reported between 25 and 29 kDa 
[28]. After the electrophoresis test (Figure not shown), 
the gel revealed a thick band at 180 kDa, which may 
correspond to the heavy chain, suggesting that this 
chain could have a higher molecular weight, due to 
the thickness of the band. A less noticeable band was 
observed at approximately 25 kDa, which is attributed 
to the light chain of fibroin, thus reaffirming the high 
possibility that the band at 180 kDa corresponds to the 
heavy chain. Other authors suggest that the molecular 
weight distributions between 25 and 120 kDa in 
revealed polyacrylamide gels are correct for fibroin, 
since factors such as fibroin extraction conditions, 
reagents and temperature may influence the results 
directly [44].
C. Characterization of SF/nHA substitutes
1) In vitro degradation and water uptake: The 
resulting degradation percentages (Fig. 4a and 
4b) show the lack of similar patterns among the 
compositions, indicating the absence of correlation 
between fibroin concentrations and degradation. The 
replicates (M1, M2 and M3) for each composition 
exhibited a similar degradation pattern, behavior that 
can be explained considering the we used the same 
batch of fibroin for each replicate. Although we used 
the same method to extract the fibroin, the differences 
may be explained by the concentration of the final 
solution after dialysis, thus showing the influence of 
the fibroin extraction lot on the characteristics of the 
bone substitute. In general, the results show that bone 
substitutes have low degradation percentages that are 
unaffected by the amount of fibroin used, since all 
materials contained 60% nHA, which is responsible 
for the slow degradation due to its physicochemical 
properties, composition and structure. The dissolution 
mechanism of HA in composite materials occurs 
mainly through ion exchange with the medium. The 
nHA used in the bone substitutes has the phase and the 
Ca/P ratio of HA stoichiometric, making it responsible 
for the stability of the material and its low degradation 
percentages, which, being less than 30% after four 
weeks, indicates that it could allow tissue regeneration 
after implantation [6, 45].
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FIg. 4. a, b) Degradation percentages; c, d) Water uptake percentages of injectable bone substitutes SF/nHA.
Water uptake is an important property that provides 
information regarding the exchange and diffusion of 
nutrients between the material and the environment, 
and the diffusion of waste [28]. The resulting water 
uptake values (Fig. 4c and 4d) were similar among 
replicates, as in the degradation test, noting the lack 
of a direct relationship between the concentration of 
fibroin and the water uptake. Fibroin is a hydrophobic 
polymer, while HA is hydrophilic [46, 47]. Although 
there is no point of comparison to determine 
whether these values are favorable or not, a high 
percentage water uptake is not beneficial in injectable 
bone substitutes, since it directly influences their 
degradation by collapsing the material, mainly when 
it is hydrophilic, as is the case of HA; in this case, 
the addition of small percentages of fibroin allows a 
moderate water uptake due to its hydrophobic nature 
[46, 48]. Additionally, the porosity of the material 
may play an important role in the water uptake; the 
substitute is considered a non-porous material, but 
the ionic exchange with the medium provokes its 
degradation and the formation of micro-porosities that 
allow water uptake [6, 49]. Furthermore, our water 
uptake values were lower compared to those obtained 
in other studies on materials made of fibroin and 
calcium phosphates, which are usually between 42% 
and 70% [46, 47].
2) Injectability and mechanical strength: The 
injectability test aims to demonstrate that fibroin acts 
as a vehicle that facilitates the movement of solid 
particles, which are 60% of nHA, so that the material 
can be manually extruded. We chose a maximum 
limit of 300 N, since research on injectable materials 
show maximum forces between 100 and 300 N, 
which correspond to the range of force that can be 
manually applied at the time of injection without 
the help of external mechanical forces [30, 31, 50]. 
The injectability test curve (Fig. 5a) shows that, 
with a fibroin concentration of 1%, an initial force 
is required to start the injection process, though the 
force decreases as the material is extruded out of the 
syringe; in contrast, with a concentration of 1.5% the 
force increases gradually as the material is extruded; 
neither case required greater forces. The difference 
in both curves may be due to the confinement of the 
material inside the syringe, since air bubbles could 
have been left inside; however, these differences are 
not considered important on account that both cases 
had high (around 97%) injectability percentages (Fig. 
5b). Despite injectability decreases slightly when 
fibroin concentration increases, it is not enough to 
establish differences between the concentration and 
the assessed factor. In addition, we observed material 
waste in the needle and syringe walls at the end of the 
trial, even though the plunger reached its stop; this 
can result in mass differences before and after the 
injection, and therefore, we conclude that the material 
is completely injectable.
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FIg. 5. a) Injectability force versus displacement curve, b) injectability rates for injectable bone substitutes SF/nHA.
The values obtained for compressive strength indicate 
that the material is weak when deformed (Table 1); 
however, it should be noted that the test was only 
performed up to 75% deformation from the initial 
height of the specimen, due to the moist and soft 
nature of the materials manufactured. These materials 
can continue increasing the exertion with the increase 
in deformation; the elastic modulus corroborated the 
above and their values indicate that the material is very 
soft. We expected this result for this type of material due 
to the large quantity of solids dispersed in an aqueous 
polymeric solution that functions as a vehicle for the 
particles. Additionally, the mechanical properties 
decreased as the fibroin concentration increased; this 
may be due to the fibroin solution used, since at a lower 
concentration there is more water inside the material, 
and therefore, greater predominance and expression 
of the solid component (60% HA) that has a ceramic 
nature and better behavior against compression. The 
amount of GTA used involves a cross-linking with 
fibroin and, therefore, a better stabilization of the 
polymer, which is why the HA particles integrate better 
into the polymer solution decreasing the mechanical 
properties. The compressive strength and the elastic 
modulus for cortical bone range from 131-229 MPa 
and from 3- 30 GPa, while for trabecular bone range 
from 5-30 MPa and from 0.02-17 MPa, respectively 
[51-54]. Although our values of the mechanical 
properties were lower to those reported for bone, it is 
important to emphasize that since the main potential 
application of the material is for filling bone cavities, 
we expect to see an increase in these properties once 
implanted, due to cellular colonization and the HA 
calcification and new bone formation [53, 55].
tablE 1
Bone suBstitute and meChaniCal pRopeRties
Composition Compressive strength (MPa) Elastic modulus (MPa)
SF 1% - GTA 0.25% 0.156 ± 0.031 0.073 ± 0.022
SF 1.5% - GTA 0.25% 0.112 ± 0.012 0.044 ± 0.011
IV. conclusIons
The sintered hydroxyapatite resembled the mineral 
component of human bone, showing typical 
characteristics of a stoichiometric hydroxyapatite, in 
terms of phase stabilization, Ca/P ratio and nanorod 
morphology. Silk fibroin extracted from the cocoons 
of Bombyx mori showed the appropriate characteristics 
in the IR tests and molecular weight, making the 
process suitable to obtain a material that can be used 
for medical applications.
Injectable bone substitutes showed good degradation 
and water uptake properties due to the high percentage 
of HA, which provides chemical stability over time, 
with low percentages of degradation and water 
uptake, giving an idea of the material’s behavior after 
implantation. However, these properties depend on 
the fibroin extraction batch. The fibroin is a vehicle 
for particle movement that facilitates the manual 
injection of the substitutes. Although the mechanical 
resistance is considered low for bone applications, 
this is not a negative result since the soft and moist 
nature of the material is what makes the substitute 
injectable. Moreover, once the substitute is implanted, 
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its mechanical properties should improve because of 
the cellular activity and the subsequent bone formation 
produced by the amount of HA present, which is a 
similar to that of the bones.
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